| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238706 For therapy of asthma and inflammation and useful for the enhancement of cognition |
| 07/03/2007 | US7238705 Aporphine esters and their use in therapy |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238700 A2B adenosine receptor antagonists |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238696 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 07/03/2007 | US7238487 Therapeutic agent for fibromyalgia |
| 07/03/2007 | CA2382548C Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 07/03/2007 | CA2297153C Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders |
| 07/03/2007 | CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/03/2007 | CA2168021C Vasoconstrictive dihydrobenzopyran derivatives |
| 07/03/2007 | CA2092567C Nt-4 neurotrophic factor |
| 06/28/2007 | WO2007073346A1 Water-soluble films comprising low-viscosity alginates |
| 06/28/2007 | WO2007073325A1 Method and composition for treating and diagnosing restless legs syndrome |
| 06/28/2007 | WO2007073284A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES |
| 06/28/2007 | WO2007073283A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 06/28/2007 | WO2007073117A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 06/28/2007 | WO2007072980A1 Novel application of apelin |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072974A1 P2x4 receptor antagonist |
| 06/28/2007 | WO2007072902A1 Therapeutic agent for acute cerebral infarct |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007072645A1 Method of regulating cell size and/or cell cycle |
| 06/28/2007 | WO2007072095A1 New compounds |
| 06/28/2007 | WO2007072094A1 New compounds |
| 06/28/2007 | WO2007072093A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | WO2007072092A2 New phenanthridine derivatives as bradykinin antagonists |
| 06/28/2007 | WO2007072091A1 New compounds |
| 06/28/2007 | WO2007072090A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | WO2007072070A1 New protein isoforms and uses thereof |
| 06/28/2007 | WO2007071967A2 Substituted phenol derivatives as analgesics |
| 06/28/2007 | WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | WO2007071662A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | WO2007071639A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 06/28/2007 | WO2007071598A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007071055A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | WO2007071045A1 Catecholamine regulated protein |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007054444A3 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 06/28/2007 | WO2007054436A3 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists |
| 06/28/2007 | WO2007053353A3 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 06/28/2007 | WO2007053352A3 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 06/28/2007 | WO2007050576A3 A method of preparing a 4-oxo-1- (3 substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3- carboxamide phosphodiesterase-4 inhibitor |
| 06/28/2007 | WO2007049977A3 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases. |
| 06/28/2007 | WO2007045060B1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 06/28/2007 | WO2007041697A3 Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease |
| 06/28/2007 | WO2007041257A3 Substituted propylamine derivatives and methods of their use |
| 06/28/2007 | WO2007038551A3 Use of ibudilast for treating drug and behavioral addictions |
| 06/28/2007 | WO2007034024A3 Treatment of symptoms of parkinson' s disease |
| 06/28/2007 | WO2007033774A3 Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention |
| 06/28/2007 | WO2007016563A3 Alcohol resistant pharmaceutical formulations |
| 06/28/2007 | WO2007014943A3 Therapy for neurological diseases |
| 06/28/2007 | WO2007009800A3 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 06/28/2007 | WO2006076681A3 Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders |
| 06/28/2007 | US20070149568 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070149558 Benzo-fused 5-membered heterocyclic compounds, their production and use |
| 06/28/2007 | US20070149545 Substituted indan derivatives |
| 06/28/2007 | US20070149542 Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 06/28/2007 | US20070149492 Method of affecting sleep and sleep-related behaviors |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148643 Treatment of Huntington's Disease with EPA |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148247 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148150 MKK7 activation inhibitor |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE102006057027A1 Benzochromenderivate Benzochromene derivatives |
| 06/28/2007 | DE102005062098A1 Oxaphenanthren-Derivate Oxaphenanthren derivatives |
| 06/28/2007 | CA2634693A1 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/28/2007 | CA2634491A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | CA2634363A1 Novel application of apelin |
| 06/28/2007 | CA2634305A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 06/28/2007 | CA2634212A1 Mif inhibitors |
| 06/28/2007 | CA2634172A1 Piperidine derivatives |
| 06/28/2007 | CA2634140A1 Method and composition for treating and diagnosing restless legs syndrome |
| 06/28/2007 | CA2634056A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | CA2633878A1 Water-soluble films comprising low-viscosity alginates |
| 06/28/2007 | CA2633740A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 06/28/2007 | CA2633484A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | CA2633425A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 06/28/2007 | CA2632780A1 Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| 06/28/2007 | CA2632582A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 06/28/2007 | CA2632561A1 Substituted propofol derivatives as analgesics |
| 06/28/2007 | CA2630896A1 New compounds |
| 06/28/2007 | CA2630890A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors |